Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001821268-25-000003
Filing Date
2025-01-07
Accepted
2025-01-07 13:26:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 4895
  Complete submission text file 0001821268-25-000003.txt   6788
Mailing Address 305 COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 305 COLLEGE ROAD EAST PRINCETON NJ 08540 973-329-8885
Cytosorbents Corp (Subject) CIK: 0001175151 (see all company filings)

EIN.: 980373793 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-81910 | Film No.: 25514295
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 1200 NORTH MAYFAIR ROAD SUITE 250 MILWAUKEE WI 53226
Business Address 1200 NORTH MAYFAIR ROAD SUITE 250 MILWAUKEE WI 53226 414-256-3380
Skylands Capital, LLC (Filed by) CIK: 0001299910 (see all company filings)

EIN.: 200775613 | State of Incorp.: WI | Fiscal Year End: 1231
Type: SCHEDULE 13G